Equity-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions |
12 Months Ended | |
|---|---|---|
Sep. 28, 2024 |
Sep. 30, 2023 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Unamortized value of unvested stock options | $ 15,500 | |
| Weighted average period (years) that expense is expected to be recognized | 2 years 4 months 24 days | |
| Selling, General and Administrative Expenses | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Equity-based compensation expense | $ 8,600 | $ 11,700 |
| Common Stock | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Shares available for grant | 14.5 | |
| Employee Stock Option | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Option expiration period | 10 years | |
| Unamortized value of unvested stock options | $ 372 | |
| Weighted average period (years) that expense is expected to be recognized | 6 months | |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|